$XBiotech (XBIT.US)$ XBiotech Halts Rheumatology Program Aft...
$XBiotech (XBIT.US)$ XBiotech Halts Rheumatology Program After Phase II Rheumatoid Arthritis Study Fails To Meet Primary Endpoint Amid Data Irregularities; Future Studies On Hold Pending Further Analysis Of Findings
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more